Biomica: Raises $20M in Financing

Biomica Raises $20M in Financing

• Biomica, a Rehovot, Israel-based clinical-stage biopharmaceutical company, raised $20M in funding
• The round was led by Shanghai Healthcare Capital
• The financing is subject to customary closing conditions, including clearance by Chinese regulatory authorities
• The company intends to use the funds to develop its pipeline of microbiome-based therapeutics, complete its current BMC128 phase 1 immuno-oncology study
• The company is focused on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders